We are live on ! Find out more
DMIIU icon

Drugs Made In America Acquisition II Corp Unit
DMIIU

9 hedge funds and large institutions have $14.6M invested in Drugs Made In America Acquisition II Corp Unit in 2026 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

3.95% less ownership

Funds ownership: 6.73% → 2.77% (-4%)

18% less funds holding

Funds holding: 11 → 9 (-2)

100% less capital inflows, than outflows

Capital inflows: $83.3K | Capital outflows: $20.7M

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Clear Street
Clear Street
New York
+$83.3K

DMIIU Hedge Fund Activity: Q3 2026 in Review

9 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Unit (DMIIU) for Q3 2026, worth a combined $14.6M — down 58% from $35M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of DMIIU and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Clear Street, adding an estimated $83.3K. The largest seller was LMR Partners, exiting entirely with an estimated $20.3M sold.

  • 9 institutional investors held Drugs Made In America Acquisition II Corp Unit (DMIIU) as of Q3 2026, down from 11 in Q2 2026.
  • Funds reported $14.6M of Drugs Made In America Acquisition II Corp Unit stock for Q3 2026, down 58% quarter-over-quarter.
  • 0 funds opened new Drugs Made In America Acquisition II Corp Unit positions in Q3 2026 and 2 closed out, a net change of -2 holders.
  • The largest Drugs Made In America Acquisition II Corp Unit buyer in Q3 2026 was Clear Street, an estimated $83.3K added.
  • The largest Drugs Made In America Acquisition II Corp Unit seller in Q3 2026 was LMR Partners, an estimated $20.3M sold.

Based on aggregated 13F filings for Q3 2026.